πŸ‡ΊπŸ‡Έ FDA
Patent

US 8163779

Glucokinase activators

granted A61PA61P15/00A61P15/08

Quick answer

US patent 8163779 (Glucokinase activators) held by Takeda San Diego, Inc. expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda San Diego, Inc.
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P15/00, A61P15/08, A61P3/04, A61P3/06